420 with CNW – Chronic Pain Tops Reasons for Medical Cannabis Use in America

February 12, 2019 04:20:10

A new study has found that most Americans use medical marijuana in order to ease chronic pain. The study was aimed at finding out the exact reasons why people in the U.S. use medical marijuana, and whether those stated reasons have any scientific basis.

Kevin Boehnke, a researcher at Michigan University’s Chronic Pain and Fatigue Research Center, led the team of researchers who started by analyzing a report that was written in 2017 on the use of medical marijuana. This report was written by the National Academies of Sciences, Engineering and Medicine.

That 2017 report found either conclusive or substantial proof that cannabis eased nausea, muscle spasms, vomiting and chronic pain.

Boehnke and his team also found that in 2016, the number of people who were registered to use medical cannabis was 641,000. This number rose to 814,000 the following year (2017). However, the researchers believe that the actual number of medical cannabis users exceeds the statistics captured in the report they read.

The statistics show that 85.5 percent of medical cannabis card holders were convinced that there was science backing their desire to use medical cannabis for the different qualifying conditions they suffered from. Chronic pain topped the list of qualifying conditions taking up 62 percent of all applications for medical cannabis cards.

The team of researchers wasn’t surprised by their findings regarding chronic pain given that approximately 100 million Americans are estimated to suffer from chronic pain.

Many of those medical cannabis users, such as Brandian Smith from Illinois, say that they resorted to medical cannabis because it worked better than the prescription opiates that they had been using previously.

This anecdotal evidence from actual medical cannabis users, together with the scientific studies that prove that medical marijuana can combat chronic pain, may offer a ray of hope in the fight against the opioid crisis in the U.S.

Currently, 33 states have legalized the use of medical marijuana. 10 states, as well as the District of Columbia, have decriminalized adult-use marijuana. These 33 states can potentially start a wave rolling back the opioid problem if this matter is given more attention.

For now, the federal government remains adamant that marijuana hasn’t been proved to have any medical use, so it remains a Schedule 1 substance. Boehnke and his team of researchers feel strongly that their findings make a case for changing the federal government’s position so that cannabis can be integrated in the medical system of the country. Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) and Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) couldn’t agree more with Kevin Boehnke’s conclusions.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
303.498.7722 Office